从2001年12月起,我国开始实行药品不良反应报告制度,药品生产企业、药品经营企业和医疗机构必须经常考察本单位所生产、经营、使用的药品质量、疗效和反应。发现可能与用药有关的严重不良反应,必须及时向当地省、自治区、直辖市人民政府药品监督管理部门和卫生行政部门报告。 Since December 2001, China began to implement the Adverse Drug Reaction Reporting System. Drug manufacturing enterprises, pharmaceutical enterprises and medical institutions must regularly inspect the quality, efficacy and response of the drugs produced, operated and used by their units. If any serious adverse drug reactions may be found, it shall be reported to the drug regulatory department and the health administrative department of the people’s government of the local province, autonomous region or municipality directly under the Central Government.